@article{ATM96926,
author = {Liang Chen and Ke Yi and Hongyan Lan and Yajun Zhang and Simin Jin and Xiaoyu Mou and Hongming Xian and Weijun Fu and Rong Li},
title = {Bortezomib, epirubicin, and dexamethasone (PAD) results in superior free-progression survival compared to bortezomib, cyclophosphamide, and dexamethasone (VCD) treatment in non-transplantation newly diagnosed multiple myeloma patients aged between 50 to 65: a retrospective single-center analysis in non-transplant patients},
journal = {Annals of Translational Medicine},
volume = {10},
number = {12},
year = {2022},
keywords = {},
abstract = {},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/96926}
}